vTv Therapeutics Inc
NASDAQ:VTVT

Watchlist Manager
vTv Therapeutics Inc Logo
vTv Therapeutics Inc
NASDAQ:VTVT
Watchlist
Price: 35.14 USD 4.09% Market Closed
Market Cap: 138.5m USD

Wall Street
Price Targets

VTVT Price Targets Summary
vTv Therapeutics Inc

Wall Street analysts forecast VTVT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for VTVT is 37.74 USD with a low forecast of 35.35 USD and a high forecast of 42 USD.

Lowest
Price Target
35.35 USD
1% Upside
Average
Price Target
37.74 USD
7% Upside
Highest
Price Target
42 USD
20% Upside
vTv Therapeutics Inc Competitors:
Price Targets
300122
Chongqing Zhifei Biological Products Co Ltd
35% Upside
PBYI
Puma Biotechnology Inc
16% Downside
NRIX
Nurix Therapeutics Inc
47% Upside
CUV
Clinuvel Pharmaceuticals Ltd
106% Upside
HALO
Halozyme Therapeutics Inc
20% Upside
688180
Shanghai Junshi Biosciences Co Ltd
26% Downside
SVRA
Savara Inc
64% Upside
MDXG
MiMedx Group Inc
72% Upside

Revenue
Forecast

Revenue Estimate
vTv Therapeutics Inc

For the last 10 years the compound annual growth rate for vTv Therapeutics Inc's revenue is -4%. The projected CAGR for the next 4 years is 55%.

-4%
Past Growth
55%
Estimated Growth
Estimates Accuracy
0%
Average Miss

Operating Income
Forecast

Operating Income Estimate
vTv Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-7%
Average Miss

Net Income
Forecast

Net Income Estimate
vTv Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-77%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is VTVT's stock price target?
Price Target
37.74 USD

According to Wall Street analysts, the average 1-year price target for VTVT is 37.74 USD with a low forecast of 35.35 USD and a high forecast of 42 USD.

What is vTv Therapeutics Inc's Revenue forecast?
Projected CAGR
55%

For the last 10 years the compound annual growth rate for vTv Therapeutics Inc's revenue is -4%. The projected CAGR for the next 4 years is 55%.

Back to Top